K Health, has announced a significant milestone with the successful raising of $50 million in funding. The round was led by Claure Group, with contributions from prominent investors such as Pablo Legorreta, founder and CEO of Royalty Pharma, and existing supporters including Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.
Primary care plays a crucial role in the U.S. healthcare system, essential for improving clinical outcomes and reducing costs, with over a billion visits to primary and urgent care facilities annually. Despite its importance, the sector faces challenges such as physician burnout and fragmented care solutions, making high-quality, comprehensive care difficult to access for many. Traditional technology solutions have primarily targeted administrative efficiencies without addressing the core need for personalized care at scale.
K Health stands out as the only company with peer-reviewed, clinical-grade AI specifically designed for primary care. The platform’s AI co-pilot transforms the patient experience by conducting personalized chats, integrating relevant electronic medical records (EMRs), and providing providers with detailed medical charts and patient insights. This allows healthcare providers to focus on engaging with patients, exercising clinical judgment, and implementing comprehensive follow-up care, resulting in higher quality care at lower costs compared to traditional primary care models.
In partnership with leading health systems, K Health is also pioneering a comprehensive longitudinal care program that merges virtual and in-person care. This integrated model uses K Health’s AI co-pilot, patients’ EMRs, and health system resources to navigate care, including diagnostic tests and specialty services. The innovative approach has already enabled a 15% increase in primary care access for health systems.
“K Health solves the need to make primary care visits highly personalized by giving doctors AI superpowers that enable them to practice at the top of their license,” said Allon Bloch, founder and CEO of K Health. “Our primary care platform offers a concierge medical experience with an assigned provider and 24/7 access to care. Partnering with leading health systems like Cedars-Sinai, this model significantly enhances access, clinical outcomes, and patient experience. All you need to get care is your health insurance, a stark contrast to concierge medicine services that typically cost thousands of dollars.”
Marcelo Claure, Founder and CEO of Claure Group, expressed his confidence in K Health’s innovative approach. “As I invest in the AI landscape, I have found it incredibly difficult to discover companies making tangible, real-world progress with AI,” Claure said. “K Health is the first company I’ve seen successfully using AI to impact millions of lives. They are addressing some of healthcare’s greatest challenges by providing accessibility to faster, higher-quality, lower-cost care on a large scale.”
With over seven years of AI technology development and the use of proprietary data sets to personalize clinical care, K Health continues to make strides in improving primary care delivery. This latest funding round will further support the company’s mission to enhance access and quality of care for patients nationwide.